Table 1. CD31 Antibody Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. CD31 Antibody Market Restraints

Table 3. CD31 Antibody Market Trends

Table 4. CD31 Antibody Industry Policy

Table 5. Global CD31 Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global CD31 Antibody Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global CD31 Antibody Sales Quantity by Company, (2018-2023) & (L), Ranked Based on Sales in 2022

Table 8. Global CD31 Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global CD31 Antibody Average Selling Price (ASP) by Company, (2018-2023) & (US$/L)

Table 10. Global CD31 Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global CD31 Antibody Mergers & Acquisitions, Expansion Plans

Table 12. Global CD31 Antibody Manufacturers Product Type

Table 13. Head Office and CD31 Antibody Production Site of Key Manufacturer

Table 14. CD31 Antibody Capacity of Major Manufacturers and Future Plan

Table 15. China CD31 Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China CD31 Antibody Sales Quantity by Company, (2018-2023) & (L), Ranked Based on Sales in 2022

Table 17. China CD31 Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global CD31 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (L)

Table 19. Global CD31 Antibody Production by Region, 2018-2023, (L)

Table 20. Global CD31 Antibody Production Forecast by Region, 2024-2029, (L)

Table 21. Global Key Players of CD31 Antibody Upstream (Raw Materials)

Table 22. Global CD31 Antibody Typical Customers

Table 23. CD31 Antibody Typical Distributors

Table 24. By Type, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global CD31 Antibody Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global CD31 Antibody Sales Quantity, 2018-2029, (L)

Table 29. By Country, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global CD31 Antibody Consumption Value Market Share, 2018-2029

Table 32. By Country, Global CD31 Antibody Sales Quantity, 2018-2029, (L)

Table 33. By Country, Global CD31 Antibody Sales Quantity Market Share, 2018-2029

Table 34. BosterBio Company Information, Head Office, Market Area, and Industry Position

Table 35. BosterBio CD31 Antibody Models, Specifications, and Application

Table 36. BosterBio CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 37. BosterBio Company Profile and Main Business

Table 38. BosterBio Recent Developments

Table 39. Bio-Rad Company Information, Head Office, Market Area, and Industry Position

Table 40. Bio-Rad CD31 Antibody Models, Specifications, and Application

Table 41. Bio-Rad CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 42. Bio-Rad Company Profile and Main Business

Table 43. Bio-Rad Recent Developments

Table 44. Bioss Company Information, Head Office, Market Area, and Industry Position

Table 45. Bioss CD31 Antibody Models, Specifications, and Application

Table 46. Bioss CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 47. Bioss Company Profile and Main Business

Table 48. Bioss Recent Developments

Table 49. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position

Table 50. Thermo Fisher Scientific CD31 Antibody Models, Specifications, and Application

Table 51. Thermo Fisher Scientific CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 52. Thermo Fisher Scientific Company Profile and Main Business

Table 53. Thermo Fisher Scientific Recent Developments

Table 54. NSJ Bioreagents Company Information, Head Office, Market Area, and Industry Position

Table 55. NSJ Bioreagents CD31 Antibody Models, Specifications, and Application

Table 56. NSJ Bioreagents CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 57. NSJ Bioreagents Company Profile and Main Business

Table 58. NSJ Bioreagents Recent Developments

Table 59. R and D Systems Company Information, Head Office, Market Area, and Industry Position

Table 60. R and D Systems CD31 Antibody Models, Specifications, and Application

Table 61. R and D Systems CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 62. R and D Systems Company Profile and Main Business

Table 63. R and D Systems Recent Developments

Table 64. Abcam Company Information, Head Office, Market Area, and Industry Position

Table 65. Abcam CD31 Antibody Models, Specifications, and Application

Table 66. Abcam CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 67. Abcam Company Profile and Main Business

Table 68. Abcam Recent Developments

Table 69. BioLegend Company Information, Head Office, Market Area, and Industry Position

Table 70. BioLegend CD31 Antibody Models, Specifications, and Application

Table 71. BioLegend CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 72. BioLegend Company Profile and Main Business

Table 73. BioLegend Recent Developments

Table 74. GeneTex Company Information, Head Office, Market Area, and Industry Position

Table 75. GeneTex CD31 Antibody Models, Specifications, and Application

Table 76. GeneTex CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 77. GeneTex Company Profile and Main Business

Table 78. GeneTex Recent Developments

Table 79. Novus Biologicals Company Information, Head Office, Market Area, and Industry Position

Table 80. Novus Biologicals CD31 Antibody Models, Specifications, and Application

Table 81. Novus Biologicals CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 82. Novus Biologicals Company Profile and Main Business

Table 83. Novus Biologicals Recent Developments

Table 84. SouthernBiotech Company Information, Head Office, Market Area, and Industry Position

Table 85. SouthernBiotech CD31 Antibody Models, Specifications, and Application

Table 86. SouthernBiotech CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 87. SouthernBiotech Company Profile and Main Business

Table 88. SouthernBiotech Recent Developments

Table 89. LifeSpan BioSciences Company Information, Head Office, Market Area, and Industry Position

Table 90. LifeSpan BioSciences CD31 Antibody Models, Specifications, and Application

Table 91. LifeSpan BioSciences CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 92. LifeSpan BioSciences Company Profile and Main Business

Table 93. LifeSpan BioSciences Recent Developments

Table 94. Enzo Life Sciences Company Information, Head Office, Market Area, and Industry Position

Table 95. Enzo Life Sciences CD31 Antibody Models, Specifications, and Application

Table 96. Enzo Life Sciences CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 97. Enzo Life Sciences Company Profile and Main Business

Table 98. Enzo Life Sciences Recent Developments

Table 99. Bethyl Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 100. Bethyl Laboratories CD31 Antibody Models, Specifications, and Application

Table 101. Bethyl Laboratories CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 102. Bethyl Laboratories Company Profile and Main Business

Table 103. Bethyl Laboratories Recent Developments

Table 104. Abbexa Company Information, Head Office, Market Area, and Industry Position

Table 105. Abbexa CD31 Antibody Models, Specifications, and Application

Table 106. Abbexa CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 107. Abbexa Company Profile and Main Business

Table 108. Abbexa Recent Developments

Table 109. ProSci Company Information, Head Office, Market Area, and Industry Position

Table 110. ProSci CD31 Antibody Models, Specifications, and Application

Table 111. ProSci CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 112. ProSci Company Profile and Main Business

Table 113. ProSci Recent Developments

Table 114. Proteintech Company Information, Head Office, Market Area, and Industry Position

Table 115. Proteintech CD31 Antibody Models, Specifications, and Application

Table 116. Proteintech CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 117. Proteintech Company Profile and Main Business

Table 118. Proteintech Recent Developments

Table 119. Synaptic Systems Company Information, Head Office, Market Area, and Industry Position

Table 120. Synaptic Systems CD31 Antibody Models, Specifications, and Application

Table 121. Synaptic Systems CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 122. Synaptic Systems Company Profile and Main Business

Table 123. Synaptic Systems Recent Developments

Table 124. BIOCARE MEDICAL Company Information, Head Office, Market Area, and Industry Position

Table 125. BIOCARE MEDICAL CD31 Antibody Models, Specifications, and Application

Table 126. BIOCARE MEDICAL CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 127. BIOCARE MEDICAL Company Profile and Main Business

Table 128. BIOCARE MEDICAL Recent Developments

Table 129. CUSABIO Technology Company Information, Head Office, Market Area, and Industry Position

Table 130. CUSABIO Technology CD31 Antibody Models, Specifications, and Application

Table 131. CUSABIO Technology CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 132. CUSABIO Technology Company Profile and Main Business

Table 133. CUSABIO Technology Recent Developments

Table 134. Absolute Antibody CD31 Antibody Company Information, Head Office, Market Area, and Industry Position

Table 135. Absolute Antibody CD31 Antibody Models, Specifications, and Application

Table 136. Absolute Antibody CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 137. Absolute Antibody Company Profile and Main Business

Table 138. Absolute Antibody Recent Developments

Table 139. EpiGentek Company Information, Head Office, Market Area, and Industry Position

Table 140. EpiGentek CD31 Antibody Models, Specifications, and Application

Table 141. EpiGentek CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 142. EpiGentek Company Profile and Main Business

Table 143. EpiGentek Recent Developments

Table 144. Biorbyt Company Information, Head Office, Market Area, and Industry Position

Table 145. Biorbyt CD31 Antibody Models, Specifications, and Application

Table 146. Biorbyt CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 147. Biorbyt Company Profile and Main Business

Table 148. Biorbyt Recent Developments

Table 149. Wuhan Fine Biotech Company Information, Head Office, Market Area, and Industry Position

Table 150. Wuhan Fine Biotech CD31 Antibody Models, Specifications, and Application

Table 151. Wuhan Fine Biotech CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 152. Wuhan Fine Biotech Company Profile and Main Business

Table 153. Wuhan Fine Biotech Recent Developments

Table 154. Sino Biological Company Information, Head Office, Market Area, and Industry Position

Table 155. Sino Biological CD31 Antibody Models, Specifications, and Application

Table 156. Sino Biological CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 157. Sino Biological Company Profile and Main Business

Table 158. Sino Biological Recent Developments

List of Figures

Figure 1. CD31 Antibody Picture

Figure 2. Global CD31 Antibody Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global CD31 Antibody Sales Quantity, (L) & (2018-2029)

Figure 4. Global CD31 Antibody Average Selling Price (ASP), (2018-2029) & (US$/L)

Figure 5. China CD31 Antibody Consumption Value, (US$ million) & (2018-2029)

Figure 6. China CD31 Antibody Sales Quantity (L) & (2018-2029)

Figure 7. China CD31 Antibody Average Selling Price (ASP), (US$/L) & (2018-2029)

Figure 8. By Consumption Value, China CD31 Antibody Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China CD31 Antibody Market Share of Global, 2018-2029

Figure 10. Global CD31 Antibody Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China CD31 Antibody Key Participants, Market Share, 2022

Figure 12. Global CD31 Antibody Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global CD31 Antibody Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global CD31 Antibody Production Market Share & Forecast by Region, 2018-2029

Figure 15. CD31 Antibody Industry Chain

Figure 16. CD31 Antibody Procurement Model

Figure 17. CD31 Antibody Sales Model

Figure 18. CD31 Antibody Sales Channels, Direct Sales, and Distribution

Figure 19. Monoclonal

Figure 20. Polyclonal

Figure 21. By Type, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global CD31 Antibody Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 24. By Type, Global CD31 Antibody Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global CD31 Antibody Average Selling Price (ASP), 2018-2029, (US$/L)

Figure 26. Immunochemistry (IHC)

Figure 27. Immunofluorescence (IF)

Figure 28. Western Blot (WB)

Figure 29. Immunocytochemistry (ICC)

Figure 30. ELISA

Figure 31. Others

Figure 32. By Application, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million

Figure 33. By Application, Global CD31 Antibody Consumption Value Market Share, 2018-2029

Figure 34. By Application, Global CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 35. By Application, Global CD31 Antibody Sales Quantity Market Share, 2018-2029

Figure 36. By Application, Global CD31 Antibody Average Selling Price (ASP), 2018-2029, (US$/L)

Figure 37. By Region, Global CD31 Antibody Consumption Value Market Share, 2018-2029

Figure 38. By Region, Global CD31 Antibody Sales Quantity Market Share, 2018-2029

Figure 39. North America CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America CD31 Antibody Consumption Value Market Share, 2022

Figure 41. Europe CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe CD31 Antibody Consumption Value Market Share, 2022

Figure 43. Asia Pacific CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific CD31 Antibody Consumption Value Market Share, 2022

Figure 45. South America CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America CD31 Antibody Consumption Value Market Share, 2022

Figure 47. Middle East & Africa CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 49. By Type, U.S. CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 50. By Application, U.S. CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 51. Europe CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 52. By Type, Europe CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 53. By Application, Europe CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 54. China CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 55. By Type, China CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 56. By Application, China CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 57. Japan CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 58. By Type, Japan CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 59. By Application, Japan CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 60. South Korea CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 61. By Type, South Korea CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 62. By Application, South Korea CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 63. Southeast Asia CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 64. By Type, Southeast Asia CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 65. By Application, Southeast Asia CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 66. India CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 67. By Type, India CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 68. By Application, India CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 69. Middle East & Africa CD31 Antibody Sales Quantity, 2018-2029, (L)

Figure 70. By Type, Middle East & Africa CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 71. By Application, Middle East & Africa CD31 Antibody Sales Quantity Market Share, 2022 VS 2029

Figure 72. Research Methodology

Figure 73. Breakdown of Primary Interviews

Figure 74. Bottom-up and Top-down Approaches

Figure 75. Top-down Approaches